ERRO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 5.452
EU - Europa 2.365
AS - Asia 2.217
SA - Sud America 351
OC - Oceania 27
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.438
Nazione #
US - Stati Uniti d'America 5.410
SG - Singapore 912
IT - Italia 654
CN - Cina 529
RU - Federazione Russa 495
UA - Ucraina 354
BR - Brasile 325
IE - Irlanda 301
TR - Turchia 272
DE - Germania 180
SE - Svezia 167
VN - Vietnam 163
KR - Corea 155
HK - Hong Kong 90
FI - Finlandia 52
GB - Regno Unito 41
IN - India 38
EE - Estonia 36
NL - Olanda 24
CA - Canada 23
AT - Austria 21
AU - Australia 14
NZ - Nuova Zelanda 13
CZ - Repubblica Ceca 12
IQ - Iraq 11
MX - Messico 11
BD - Bangladesh 9
ZA - Sudafrica 8
AR - Argentina 7
AE - Emirati Arabi Uniti 6
JP - Giappone 6
BE - Belgio 5
IR - Iran 5
MA - Marocco 5
CO - Colombia 4
DO - Repubblica Dominicana 4
KE - Kenya 4
CL - Cile 3
DZ - Algeria 3
EC - Ecuador 3
FR - Francia 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
PK - Pakistan 3
PL - Polonia 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
BO - Bolivia 2
EU - Europa 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
UY - Uruguay 2
VE - Venezuela 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
NP - Nepal 1
PH - Filippine 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.438
Città #
Ann Arbor 1.219
Princeton 848
Chandler 538
Wilmington 494
Jacksonville 427
Singapore 303
Dublin 295
Izmir 265
Woodbridge 216
Ashburn 194
Houston 188
Salerno 186
Dong Ket 162
Moscow 152
Andover 127
Pellezzano 121
Nanjing 115
Naples 96
Hong Kong 90
Beijing 79
Boardman 69
Norwalk 69
Fairfield 62
Düsseldorf 44
Shenyang 43
Hebei 36
Tallinn 36
Dallas 35
Nanchang 34
Pune 34
Nuremberg 30
Dearborn 29
Changsha 28
Mestre 27
West Jordan 27
Jiaxing 26
San Diego 23
Redwood City 22
São Paulo 20
Seattle 17
Brasília 15
Cambridge 15
Rome 15
Washington 15
Lecce 14
Tianjin 14
Guangzhou 13
Los Angeles 13
Belo Horizonte 12
Falls Church 12
Amsterdam 10
Brno 10
Fort Worth 10
Orange 10
Rio de Janeiro 9
Council Bluffs 8
Jinan 8
Curitiba 7
Lappeenranta 7
London 7
Milan 7
Shanghai 7
Toronto 7
Vienna 7
Assago 6
Auckland 6
Dormagen 6
Johannesburg 6
Baghdad 5
Brussels 5
Carapicuíba 5
Casoria 5
Fortaleza 5
Guarulhos 5
New York 5
Perugia 5
Porto Alegre 5
Santa Clara 5
Santa Maria A Vico 5
Sydney 5
Uberlândia 5
Dhaka 4
Kunming 4
Marigliano 4
Munich 4
Nairobi 4
Padova 4
Prineville 4
Ribeirão Preto 4
Romano di Lombardia 4
San Francisco 4
Springfield 4
São Bernardo do Campo 4
São José dos Campos 4
Zhengzhou 4
Amman 3
Anápolis 3
Bologna 3
Canzo 3
Casablanca 3
Totale 7.238
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 139
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 127
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 125
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 125
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 114
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 113
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 110
Increased bilirubin levels in de novo Parkinson's disease 109
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 106
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 105
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 97
Malabsorption is uncommon in restless legs syndrome. 94
Gender and non motor fluctuations in Parkinson's disease: A prospective study 94
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 93
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 91
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 91
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 91
On the relationship between side of onset and cognition in Parkinson disease 89
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 89
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 89
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 88
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 88
Quitting smoking: An early non-motor feature of Parkinson's disease? 84
Early MRI findings in acquired hepatocerebral degeneration. 83
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 81
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 81
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 81
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 80
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 80
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 80
Abnormal eating behaviors in progressive supranuclear palsy. 79
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 78
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 76
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 75
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 75
Uric acid relates to dopamine transporter availability in Parkinson's disease. 74
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 74
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 74
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 74
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 73
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 73
A novel therapeutic approach for synucleinopathies 73
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 73
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 71
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 70
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 69
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 68
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 68
Non-motor correlates of smoking habits in de novo Parkinson's disease 68
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 67
Non-invasive brain stimulation for dystonia: therapeutic implications 67
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 66
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 65
Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 cases 63
The "eye of the tiger" sign in pure akinesia with gait freezing. 61
Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study. 61
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 60
Progressive Parkinsonism, Balance Difficulties, and Supranuclear Gaze Palsy 60
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 60
Hemi-restless legs syndrome induced by clebopride 59
Nutritional habits, risk, and progression of Parkinson disease 58
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 58
Mild cognitive impairment in drug-naive patients with PD is associated withcerebral hypometabolism 57
Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 57
Restless legs syndrome is a common feature of adult celiac disease 57
Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation 55
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 55
ADCY5 mutations are another cause of benign hereditary chorea 55
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials 55
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 52
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 51
Neurophysiological correlates of abnormal somatosensory temporal discrimination in dystonia 51
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 51
Midbrain MRI assessments in progressive supranuclear palsy subtypes 50
The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review 49
Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials 49
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 49
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 49
When shaking during standing points to hereditary spastic paraplegias 48
“Atypical” atypical parkinsonism: Critical appraisal of a cohort 47
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 47
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. 46
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray 46
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 46
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 46
Mental rotation and working memory in musicians’ dystonia 44
A Pilot Study of Botulinum Toxin for Jerky, Position-Specific, Upper Limb Action Tremor 44
The role of disease duration and severity on novel clinical subtypes of Parkinson disease 44
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 43
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 42
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies 42
Why do people google movement disorders? An infodemiological study of information seeking behaviors 42
Seizures and movement disorders: Phenomenology, diagnostic challenges and therapeutic approaches 41
The Distinguishing Motor Features of Cataplexy: A Study from Video Recorded Attacks 40
Does rest tremor exclude the diagnosis of adult-onset primary dystonia? 40
Motor, cognitive and behavioral differences in MDS PSP phenotypes 40
Functional gait disorders: Demographic and clinical correlations 40
Parkinsonism following neuroleptic exposure: a double-hit hypothesis? 39
Propriospinal myoclonus: Clinical reappraisal and review of literature 39
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 39
Totale 6.894
Categoria #
all - tutte 55.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020266 0 0 0 0 0 0 0 0 0 0 243 23
2020/2021679 2 45 57 11 77 60 70 6 58 2 81 210
2021/20221.275 5 1 5 9 24 8 17 37 146 164 216 643
2022/20231.556 242 102 73 141 171 371 18 129 202 8 66 33
2023/20241.005 45 132 57 61 46 120 37 77 49 66 55 260
2024/20252.286 84 40 50 121 116 342 372 261 452 422 26 0
Totale 11.019